Merck Serono in discovery deal to plump up immuno-oncology pipeline

Save

Merck Serono, the biopharmaceutical arm of Merck of Germany, has signed an agreement with German biotech MorphoSys to discover and develop therapeutic antibodies against undisclosed immune checkpoints with the aim of developing new immune-oncology…